Literature DB >> 27613720

Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.

R Balogh1,2,3, J Wood4, K Dobranowski5, E Lin6,7, A Wilton6, S B Jaglal6,8, M Gemmill9, Y Lunsky6,7.   

Abstract

Individuals with intellectual and developmental disabilities (IDD) are at risk for low-trauma fractures. We investigated the rate of low-trauma fractures and the odds of BMD testing in adults with/without IDD. Adults with IDD were more likely to have a low-trauma fracture, but there was no difference in bone mineral density (BMD) testing rates.
INTRODUCTION: Individuals with IDD are at increased risk for developing osteoporosis which contributes to high rates of low-trauma fracture. Low-trauma fractures can lead to significant pain and further decrease mobility. It is therefore important to effectively manage osteoporosis, for example, by monitoring BMD in persons with IDD. The objective of this study was to examine the rates of low-trauma fracture and BMD testing among a population-based cohort of people with IDD and compare them to those without IDD.
METHODS: Using administrative data, we created a cohort of adults with IDD between the ages of 40 and 64. They were compared to a random 20 % sample of those without IDD. The number of low-trauma fractures and BMD tests in each group were determined for Ontario residents between April 1, 2009 and March 31, 2010.
RESULTS: Adults with IDD were approximately three times more likely to experience a low-trauma fracture than adults without IDD. The largest disparity in prevalence of low-trauma fractures between those with and without IDD was for men, older adults (60-64 years old) and those living in rural or lower-income neighbourhoods. Post low-trauma fracture, there was no significant difference in the likelihood of receiving a BMD test between individuals with and without IDD.
CONCLUSIONS: The findings of this study have a number of important implications related to early detection, prevention and proper management of osteoporosis and low-trauma fractures among persons with IDD.

Entities:  

Keywords:  Bone mineral density; Intellectual and developmental disability; Low-trauma fracture; Osteoporosis

Mesh:

Year:  2016        PMID: 27613720     DOI: 10.1007/s00198-016-3740-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  7 in total

1.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

2.  Consensus guidelines for primary health care of adults with developmental disabilities.

Authors:  William F Sullivan; John Heng; Donna Cameron; Yona Lunsky; Tom Cheetham; Brian Hennen; Elspeth A Bradley; Joseph M Berg; Marika Korossy; Cynthia Forster-Gibson; Maria Gitta; Chrissoula Stavrakaki; Bruce McCreary; Irene Swift
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

3.  Primary care of adults with developmental disabilities: Canadian consensus guidelines.

Authors:  William F Sullivan; Joseph M Berg; Elspeth Bradley; Tom Cheetham; Richard Denton; John Heng; Brian Hennen; David Joyce; Maureen Kelly; Marika Korossy; Yona Lunsky; Shirley McMillan
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

4.  Using administrative health data to identify individuals with intellectual and developmental disabilities: a comparison of algorithms.

Authors:  E Lin; R Balogh; V Cobigo; H Ouellette-Kuntz; A S Wilton; Y Lunsky
Journal:  J Intellect Disabil Res       Date:  2012-11-01

5.  Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities.

Authors:  Kathleen C Watson; Martha J Lentz; Kevin C Cain
Journal:  Womens Health Issues       Date:  2006 Nov-Dec

6.  Fracture epidemiology and control in a developmental center.

Authors:  G S Lohiya; F M Crinella; L Tan-Figueroa; S Caires; S Lohiya
Journal:  West J Med       Date:  1999-04

7.  Using an accumulation of deficits approach to measure frailty in a population of home care users with intellectual and developmental disabilities: an analytical descriptive study.

Authors:  Katherine McKenzie; Hélène Ouellette-Kuntz; Lynn Martin
Journal:  BMC Geriatr       Date:  2015-12-18       Impact factor: 3.921

  7 in total
  3 in total

1.  Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines.

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

2. 

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

3.  Bone health, intellectual disability and epilepsy: An observational community-based study.

Authors:  Robert Winterhalder; Joanne McCabe; Charlotte Young; Kirsten Lamb; Indermeet Sawhney; Caryn Jory; Maire O'Dwyer; Rohit Shankar
Journal:  Acta Neurol Scand       Date:  2022-03-17       Impact factor: 3.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.